On September 3, 2024, Cingulate Inc., a company listed on the Nasdaq Capital Market under the trading symbols CING for its common stock and CINGW for its warrants, filed a Form 8-K with the SEC to report an increase in the maximum aggregate offering price of its common stock. The offering price was raised from $11,326,658 to $15,196,658 under the At The Market Offering Agreement with H.C. Wainwright & Co., LLC, which was originally dated January 3, 2023. This adjustment allows for an additional $3,870,000 in shares to be offered. Prior to this increase, Cingulate Inc. had already sold shares amounting to $11,323,947.19 under the same Sales Agreement. The company, identified as an emerging growth company, also filed a prospectus supplement for the newly available shares and included a legal opinion from Lowenstein Sandler LLP regarding the legality of the shares issuable under the Sales Agreement.

On September 3, 2024, Cingulate Inc., a company listed on the Nasdaq Capital Market under the trading symbols CING for its common stock and CINGW for its warrants, filed a Form 8-K with the SEC to report an increase in the maximum aggregate offering price of its common stock. The offering price was raised from $11,326,658 to $15,196,658 under the At The Market Offering Agreement with H.C. Wainwright & Co., LLC, which was originally dated January 3, 2023. This adjustment allows for an additional $3,870,000 in shares to be offered. Prior to this increase, Cingulate Inc. had already sold shares amounting to $11,323,947.19 under the same Sales Agreement. The company, identified as an emerging growth company, also filed a prospectus supplement for the newly available shares and included a legal opinion from Lowenstein Sandler LLP regarding the legality of the shares issuable under the Sales Agreement.